Lv2
150 积分 2026-02-25 加入
Immunocyte lipid metabolic reprogramming: a novel pathway for targeted intervention in autoimmune diseases
1个月前
已完结
Soluble ST2 is increased in systemic lupus erythematous and is a potential marker of lupus nephritis
1个月前
已完结
Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells
1个月前
已完结
Therapeutic Opportunities of Interleukin-33 in the Central Nervous System
1个月前
已完结
Plasma Interleukin-33 level in relapsing-remitting multiple sclerosis. Is it negatively correlated with central nervous system lesions in patients with mild disability?
1个月前
已完结
Interleukin-33 Ameliorates Murine Systemic Lupus Erythematosus and Is Associated with Induction of M2 Macrophage Polarisation and Regulatory T Cells
1个月前
已完结
Modulation of IL33/ST2 axis and mucosal healing in IBD: state of the art and future perspectives
1个月前
已完结
IL-33 Drives Expansion of Type 2 Innate Lymphoid Cells and Regulatory T Cells and Protects Mice From Severe, Acute Colitis
1个月前
已完结
IL-33 Neutralization Suppresses Lupus Disease in Lupus-Prone Mice
1个月前
已完结
Emerging Roles of IL-33/ST2 Axis in Renal Diseases
1个月前
已完结
皖公网安备34019202002308
